SUV39H1 and Miyoshi myopathy: Importantly, the selective inhibition of SUV39H1, achieved using either small molecule or conditional shRNA-based approaches, is responsible for reduced MM cell proliferation, cell cycle arrest, enhanced DNA damage, and induction of the apoptotic phenotype in MM cells [57].